We are live on ! Find out more
ONCY

ONCOLYTICS BIOTECH INC

Delisted

ONCY was delisted on the 4th of November, 2015.

27 hedge funds and large institutions have $245K invested in ONCOLYTICS BIOTECH INC in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more call options, than puts

Call options by funds: $17K | Put options by funds: $4K

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

16% less funds holding

Funds holding: 3227 (-5)

67% less capital invested

Capital invested by funds: $746K → $245K (-$501K)

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Holders
27
Holders Change
-5
Holders Change %
-15.63%
% of All Funds
0.75%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
7
Reduced
6
Closed
6
Calls
$17K
Puts
$4K
Net Calls
+$13K
Net Calls Change

ONCY Hedge Fund Activity: Q3 2015 in Review

27 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in ONCOLYTICS BIOTECH INC (ONCY) for Q3 2015, worth a combined $245K — down 67% from $746K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ONCY and 1 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 7 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $21.9K. The largest seller was Canada Pension Plan Investment Board, exiting entirely with an estimated $135K sold.

  • 27 institutional investors held ONCOLYTICS BIOTECH INC (ONCY) as of Q3 2015, down from 32 in Q2 2015.
  • Funds reported $245K of ONCOLYTICS BIOTECH INC stock for Q3 2015, down 67% quarter-over-quarter.
  • 1 fund opened new ONCOLYTICS BIOTECH INC positions in Q3 2015 and 6 closed out, a net change of -5 holders.
  • The largest ONCOLYTICS BIOTECH INC buyer in Q3 2015 was Citadel Advisors, an estimated $21.9K added.
  • The largest ONCOLYTICS BIOTECH INC seller in Q3 2015 was Canada Pension Plan Investment Board, an estimated $135K sold.

Based on aggregated 13F filings for Q3 2015.